Search results
...At Freddy’s’ Defies Theatrical Day-And-Date Odds, Is No. 8 In Deadline’s 2023 Most Valuable ...
Deadline Hollywood· 1 day agoDeadline’s Most Valuable Blockbuster tournament is back. While studios during Covid wildly embraced...
First trial over Zantac cancer claims set to begin in Chicago
Reuters via Yahoo News· 8 hours ago(Reuters) -The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and...
Ozempic Maker Novo Nordisk Has Denmark’s Economy Hooked
Bloomberg· 7 hours agoThe blockbuster drug producer is Europe’s most valuable company — and its home country is feeling...
James Gunn Promises That Superman’s Flying Sequences Will Be ‘Much More Complex’ Than What Was Done...
CinemaBlend via Yahoo News· 9 hours agoAnd this issue currently sits in the lap of James Gunn, who is hard at work on his 2025 summer ...
‘Wonka’ Reawakens The Movie Musical To Land At No. 6 In Deadline’s 2023 Most Valuable Blockbuster...
Deadline via Yahoo News· 9 hours agoDeadline’s Most Valuable Blockbuster tournament is back. While studios during Covid wildly embraced...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
San Francisco Chronicle· 7 hours agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
Nebraska parish mobilizes to help neighbors after massive tornado
Catholic News Agency· 12 hours agoAfter a blockbuster night of severe weather that saw tornadoes touch down in at least six states on...
Knicks a ‘Prime Candidate’ for Blockbuster Trade to Finally Add Kevin Durant: NBA Exec
Heavy.com· 13 hours agoIn the spring of 2019, the Knicks were all set up for a monumental NBA offseason. ESPN’s Stephen A....
Playmate’s Lawyer Offered Tabloid ‘Blockbuster’ Trump Story
Bloomberg via Yahoo News· 7 hours ago(Bloomberg) -- The jury in Donald Trump’s hush money trial heard the most vivid testimony yet about...
US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition
Las Vegas Review-Journal· 4 hours agoWASHINGTON — Federal regulators are challenging patents on 20 brand-name drugs, including the ...